Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation

JAMA Neurol. 2016 Nov 1;73(11):1375. doi: 10.1001/jamaneurol.2016.3199.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Fingolimod Hydrochloride*
  • Humans
  • Immunosuppressive Agents
  • Multiple Sclerosis*
  • Multiple Sclerosis, Relapsing-Remitting

Substances

  • Immunosuppressive Agents
  • Fingolimod Hydrochloride